Sarepta Therapeutics | SRPT - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
Agios Pharmaceuticals USD 1.61B 598M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.95B 667M 2026-11
Capricor Therapeutics USD 1.66B 1.33B 2025-12
Daiichi Sankyo JPY 5.22T 356.74B 2026-09
Eli Lilly USD 1.09T 40.33B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
Incyte USD 24.6B 1.95B 2026-09
Insmed USD 24.93B 1.82B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Moderna USD 99.14B 22.26B 2026-11
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 14.46B 45M 2026-11
Novavax USD 1.09B 316M 2025-12
Pfizer USD 169.88B 6.47B 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 100.56B 13.53B 2026-11
Sarepta Therapeutics USD 1.65B 276M 2026-11
Tectonic Therapeutic USD 649M 69M 2026-06
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
Vertex Pharmaceuticals USD 142.88B 10.37B 2026-11